Currently, there are 1.13B common shares owned by the public and among those 1.11B shares have been available to trade.
The company’s stock has a 5-day price change of -0.06% and -2.60% over the past three months. SBUX shares are trading 1.99% year to date (YTD), with the 12-month market performance up to 0.14% higher. It has a 12-month low price of $71.55 and touched a high of $103.32 over the same period. SBUX has an average intraday trading volume of 8.01 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 1.46%, -3.35%, and 5.48% respectively.
Institutional ownership of Starbucks Corp (NASDAQ: SBUX) shares accounts for 78.28% of the company’s 1.13B shares outstanding.
It has a market capitalization of $105.52B and a beta (3y monthly) value of 0.97. The stock’s trailing 12-month PE ratio is 28.15, while the earnings-per-share (ttm) stands at $3.31. The company has a PEG of 3.32 and a Quick Ratio of 0.56. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.79% over the week and 2.17% over the month.
Analysts forecast that Starbucks Corp (SBUX) will achieve an EPS of 0.68 for the current quarter, 0.59 for the next quarter and 3.73 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0.59 while analysts give the company a high EPS estimate of 0.59. Comparatively, EPS for the current quarter was 0.9 a year ago. Earnings per share for the fiscal year are expected to decrease by -5.47%, and 18.85% over the next financial year. EPS should grow at an annualized rate of 8.49% over the next five years, compared to 2.53% over the past 5-year period.
Looking at the support for the SBUX, a number of firms have released research notes about the stock. RBC Capital Mkts stated their Outperform rating for the stock in a research note on November 15, 2024, with the firm’s price target at $115. Redburn Atlantic coverage for the Starbucks Corp (SBUX) stock in a research note released on November 13, 2024 offered a Sell rating with a price target of $77. Morgan Stanley was of a view on October 17, 2024 that the stock is Overweight, while BTIG Research gave the stock Buy rating on October 17, 2024, issuing a price target of $100- $115. Bernstein on their part issued Outperform rating on September 26, 2024.
